Concord Drugs Key Metrics

BSE: - | NSE: - | ISIN: - | Sector: -

87.50 +3.73 (4.45%)Updated : 21 Apr 2026

Ratios

Return on average equity - 5 year average	4.46
Net Income/employee - trailing 12 month	0.00
Revenue/employee - most recent fiscal year	0.00
Return on investment - most recent fiscal year	0.88
Return on average assets - most recent fiscal year	0.54
Receivables turnover - most recent fiscal year	2.71
Return on investment - trailing 12 month	0.00
Return on average assets - trailing 12 month	0.00
Inventory turnover - most recent fiscal year	1.46
Inventory turnover - trailing 12 month	0.00
Revenue/employee - trailing 12 month	0.00
Return on average assets - 5 year average	2.34
Net Income/employee - most recent fiscal year	0.00
Return on average equity - trailing 12 month	0.00
Receivables turnover - trailing 12 month	0.00
Asset turnover - most recent fiscal year	0.73
Asset turnover - trailing 12 month	0.00
Return on average equity - most recent fiscal year	0.99
Return on investment - 5 year average	3.83